Belief BioMed ("BBM") today announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been officially approved by the Pharmaceutical Administration Bureau of Macao Special ...
The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...
In his complaint, Michael Wade Nance said his veins were so severely compromised that they were likely to blow and cause him ...
The high-dose Wegovy helped patients with obesity lose an average 20.7% of their weight after 72 weeks in a phase three trial.
However, experts said there’s limited scientific evidence that many peptides are safe and effective. Peptides are having a moment, promoted by everyone from wellness influencers and celebrities to ...
UCSF scientists found a precise way to turn on cancer-fighting immune cells inside the body. This more potent form of CAR-T ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated ...
Immunotherapy has transformed cancer treatment by harnessing the body's own immune system to fight disease. But many engineered immune cells lose strength quickly after they enter the body, especially ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an ...
ORNL is a leader both in developing advanced radiotherapies and in providing the radioisotopes needed for those therapies.
A new RNA-based therapy developed at Columbia University could help the heart repair itself after a heart attack without invasive surgery.
The PIS elicited a potent immune response as measured by local skin tests and immunological assays.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results